Sales & Marketing News | pharmaphorum

News

Vertex Pharmaceutical's Boston headquarters

FDA clears two sickle-cell gene therapies, including CRISPR ...

The US FDA has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.

News

Medtronic drops $738m takeover of wearable insulin pump firm

Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have been “multiple b

News

Biden may order compulsory licensing in drug pricing move

The White House said today that it may take enforced ownership of patents on medicines developed with public funding if their manufacturers set their prices too high.

News

Ipsen/Genfit eye June FDA verdict for liver drug elafibranor

The FDA has kicked off a priority review of Genfit and Ipsen’s elafibranor as a treatment for rare cholestatic liver disease primary biliary cholangitis (PBC), setting a d

News

Sanofi says new drugs can add €10bn to sales by 2030

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of th

News

AbbVie swoops on Pfizer spin-out Cerevel with $8.7bn offer

AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist Cerevel Therapeutics, w

FDA clears two sickle-cell gene therapies, including CRISPR ...

Medtronic drops $738m takeover of wearable insulin pump firm

Biden may order compulsory licensing in drug pricing move

Ipsen/Genfit eye June FDA verdict for liver drug elafibranor

Sanofi says new drugs can add €10bn to sales by 2030

AbbVie swoops on Pfizer spin-out Cerevel with $8.7bn offer

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks